Showing results (371-380 of 520) with videos related to
Sort By:
Pageof 52
Psychopharmacology|January 1, 1987
The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic functionS R Hirsch, R Richardson-Andrews, B Costall, et al.The Journal of General Virology|November 1, 1989
Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopesJ Cason, D Patel, J Naylor, et al.Journal of Neural Transmission. Supplementum|January 1, 1986
Neuropharmacological manipulations with MPTPN J Barnes, A J Bradbury, B Costall, et al.Equine Veterinary Journal|July 20, 2010
Histopathology and computed tomography of age-associated degeneration of the equine temporohyoid jointR J Naylor, J D Perkins, S Allen, et al.Equine Veterinary Journal|June 12, 2014
Suspected acorn toxicity in nine horsesS Smith, R J Naylor, E J Knowles, et al.International Journal of Circumpolar Health|January 5, 2002
The Alaska Native diabetes programC D Schraer, A M Mayer, A M Vogt, et al.Bone Reports|November 10, 2025
Integrating intrinsic musculoskeletal pathology and genetics: Recent advances in unravelling the causative factors of adolescent idiopathic scoliosisEllie H Northall, Liam M Grover, Helen M McGettrick, et al.Journal of Shoulder and Elbow Surgery|October 18, 2019
Next-generation sequencing for diagnosis of infection: is more sensitive really better?Allison J Rao, Ian S MacLean, Amanda J Naylor, et al.Neuropharmacology|May 1, 1990
Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferretB Costall, A M Domeney, R J Naylor, et al.Vaccine|April 14, 2015
Subpopulations in aMPV vaccines are unlikely to be the only cause of reversion to virulenceG Franzo, C J Naylor, M Drigo, et al.Pageof 52